Transplantation
258 articles · 8 journals
Journals in this subcategory (8)
- Transplantation Proceedings · Elsevier (90)
- Cytotherapy · Elsevier (58)
- Transplant Immunology · Elsevier (45)
- Pediatric Transplantation · Wiley (30)
- Clinical Transplantation · Wiley (21)
- Bone Marrow Transplantation · Springer Nature (8)
- Xenotransplantation · Wiley (6)
- Renal Replacement Therapy · Springer Nature (0)
- Early haploidentical hematopoietic stem cell transplantation for SMARCD2-related neutrophil-specific granule deficiency in infancy: A case report
- HLA One-Way Mismatch as a Definitive Risk Factor for Graft-versus-Host Disease and Mortality in Living Donor Liver Transplantation
- Early Corticosteroid Protocols in Liver Transplantation: A Survey of Canadian and American Centers
- Global Status and Research Trends of Heart Transplantation: A Bibliometrics Analysis
- Long-Term Outcomes of Heart Transplantation Using Hepatitis C–Positive Donors
- Outcomes of Lung Transplant Recipients Hospitalized With COVID-19 Infection in the Post-Acute Pandemic Era: A Nationwide Inpatient Analysis in the United States
- Demographic, Clinical, and Allocation Shifts in the US Lung Transplant Waitlist: A National SRTR Study (2012-2023)
- Association Between Perioperative Use of Fourth- Versus First-Generation Cephalosporins and Early Bacterial Infections, Chronic Lung Allograft Dysfunction-Free Survival, and 1- and 5-Year Survival: A Cohort Study
- Successful Heart and Renal Allograft Transplantation From Patients With Child-Pugh Class C Cirrhosis
- The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis
- Multinational Retrospective Chart Review of Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Solid Organ Transplant Recipients With Refractory/Resistant Cytomegalovirus Infection or Intolerance to Anti-Cytomegalovirus Therapy
- Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling
- Effects of Dexmedetomidine Preconditioning on Hepatic Ischemia-Reperfusion Injury in Rats
- Risk Factors and Clinical Predictors of Urinary Tract Infections in Kidney Transplant Recipients: A Retrospective Single-Center Study
- The Role of Varying Cardiac Troponin Levels in Long-Term Mortality in Liver Transplant Patients
- Inadvertent Coronary Sinus Cannulation During Central Venous Catheter Placement in a Liver Transplant Recipient with Persistent Left Superior Vena Cava: A Case Report
- It Is Possible to Save the Kidney With Renal Artery Occlusion Without Autotransplantation: A Case Report
- Out of Specification frameworks may overestimate clinical risk: a lesson from commercial CAR-T products deviations
- Interferon γ MSC accumulation in the lungs is mediated by integrin α4β1 adhesion
- What Drives Investment in Cell and Gene Therapy? Evidence from a Global Investor Survey of 100 Investors
- Mycophenolate Mofetil-Induced Hypofibrinogenemia: A Case Report
- Incidentally Diagnosed Pulmonary Embolism Two Months After Living Liver Donation in a Donor With Homozygous MTHFR A1298C Mutation: A Case Report
- Resilience and Rearrangement of Deceased Organ Donation Activity in 27 European Union Countries After COVID-19 Pandemic
- Sequential Liver, Kidney, and Heart Transplantation in a Single Recipient: Long-Term Survival Complicated by Chronic Renal Allograft Failure, Lung Cancer, and Recurrent Infection—A Case Report
- Post-Transplant Lymphoproliferative Disorder After Successful Treatment of Graft-Versus Host Disease Following Liver Transplantation
- Sustainable Point-of-Care Manufacturing of Cell and Gene Therapies: Operational, Regulatory and Economic Pathways for Implementation
- Drug or Medical Technology? China’s Dual-Track Regulation of Cell and Gene Therapy under State Council Order No. 818
- Safety, efficacy, and PK/PD of a BCMA-targeted CAR-NK cell therapy (LUCAR-B68) in relapsed/refractory multiple myeloma: a phase I study
- Clinical trials with Advanced Therapy Medicinal Products in Europe (2016–2025): the Regulators’ analysis
- Significant Differences in Infrastructure, Financing, and Workforce exist across Cell Therapy Manufacturing Facilities. A Report from BEST Collaborative.